EMAIL THIS PAGE TO A FRIEND

Journal of cardiovascular pharmacology

Hemodynamic effects of a poly(ethylene oxide) drag-reducing polymer, Polyox WSR N-60K, in the open-chest rat.


PMID 2476615

Abstract

The acute hemodynamic effects of an intravenously (i.v.) injected poly(ethylene oxide), Polyox WSR N-60K (dose 50 mg/kg), were studied in the open-chest rat anesthetized with sodium pentobarbital. The injectate is one of four drag-reducing polymers known to augment in vitro blood flow under a constant pressure gradient; the others are an anionic polyacrylamide (Separan), a rhamnogalactogalacturonan (RGGu), and a deoxyribonucleic acid (calf thymus DNA). RGGu and Separan both augment cardiac output in the rat. Aortic blood flow, measured with an electromagnetic flow probe mounted on the ascending aorta, increased immediately after administration of the polymer and remained above control flow for at least 1 h. A small sustained decrease in heart rate (HR) was associated with a prolongation of systole. Ventricular and arterial blood pressures increased progressively over the 2-h postinjection period. Total peripheral resistance (TPR) initially decreased but then increased continuously throughout the experimental period, eventually surpassing the control value. Although the in vivo effects of Polyox differ from those of RGGu and Separan, the effects of the three macromolecules on aortic flow and TPR are similar at least in the first hour. Because the three substances are chemically dissimilar, these results further support the hypothesis that the primary mechanism responsible for the hemodynamic changes caused by some drag-reducing polymers--apparently limited to those with molecular lengths approaching 100 microns--is physical in nature.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

91462
Kollisolv® PEG E 300
06855
Kollisolv® PEG E 400
P3015
Poly(ethylene glycol), average mol wt 200
81260
Poly(ethylene glycol), average Mn 6,000
202398
Poly(ethylene glycol), average Mn 400
P4338
Poly(ethylene glycol), BioXtra, average mol wt 3,350, powder
P5413
Poly(ethylene glycol), for molecular biology, average mol wt 8,000
89510
Poly(ethylene glycol), BioUltra, 8,000
P2139
Poly(ethylene glycol), average mol wt 8,000, powder
81268
Poly(ethylene glycol), BioUltra, for molecular biology, 8,000
95904
Poly(ethylene glycol), BioUltra, 4,000
81253
Poly(ethylene glycol), BioUltra, for molecular biology, 6,000
81172
Poly(ethylene glycol), tested according to Ph Eur, 400
81240
Poly(ethylene glycol), average Mn 4,000, platelets
81255
Poly(ethylene glycol), BioUltra, 6,000
81300
Poly(ethylene glycol), average Mn 20,000
81188
Poly(ethylene glycol), BioUltra, 1,000
202371
Poly(ethylene glycol), average Mn 300
88276
Poly(ethylene glycol), BioUltra, 3,350
202444
Poly(ethylene glycol), average Mn 3,350, powder
91893
Poly(ethylene glycol), BioUltra, 400
P3265
Poly(ethylene glycol), average mol wt 400
81310
Poly(ethylene glycol), 35,000
95172
Poly(ethylene glycol), BioUltra, 20,000
84797
Poly(ethylene glycol), BioUltra, 2,000
202401
Poly(ethylene glycol), average Mn 600, waxy solid (moist)
P6667
Poly(ethylene glycol), average mol wt 10,000
81210
Poly(ethylene glycol), average Mw 1,500
81242
Poly(ethylene glycol), tested according to Ph Eur, 4,000
94646
Poly(ethylene glycol), BioUltra, 35,000